TherapeuticsMD, Inc. 8-K

What Happened
TherapeuticsMD, Inc. (a Nevada corporation) filed a Current Report on Form 8-K on March 30, 2026 to disclose its full-year 2025 financial results. The company issued a press release titled “TherapeuticsMD Announces Full Year 2025 Financial Results,” which is furnished as Exhibit 99.1 to the 8-K and is incorporated by reference. The filing is made under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure).

Key Details

• Press release dated March 30, 2026 announcing financial results for the year ended December 31, 2025 (Exhibit 99.1).
• Disclosure made under Item 2.02 (results of operations/financial condition) and Item 7.01 (Regulation FD).
• Interactive XBRL cover page file included as Exhibit 104.
• The 8-K furnishes the press release; readers should consult Exhibit 99.1 for the specific revenue, earnings, cash flow, or guidance figures.

Why It Matters
This 8-K signals that TherapeuticsMD has publicly released its full-year 2025 earnings information—material data investors use to assess performance and valuation. Because the filing furnishes the press release and triggers Regulation FD disclosure, investors should read the attached press release (Exhibit 99.1) and any related SEC filings for the precise financial metrics, trends, and management commentary before making investment decisions.